http://rdf.ncbi.nlm.nih.gov/pubchem/reference/21490948

Outgoing Links

Predicate Object
contentType Journal Article
issn 1931-7573
1556-276X
issueIdentifier 1
pageRange 260-
publicationName Nanoscale Research Letters
startingPage 260
bibliographicCitation Sanna V, Roggio AM, Posadino AM, Cossu A, Marceddu S, Mariani A, Alzari V, Uzzau S, Pintus G, Sechi M. Novel docetaxel-loaded nanoparticles based on poly(lactide-co-caprolactone) and poly(lactide-co-glycolide-co-caprolactone) for prostate cancer treatment: formulation, characterization, and cytotoxicity studies. Nanoscale Research Letters. 2011 Mar 28;6(1):260. doi: 10.1186/1556-276x-6-260.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d4133519a3ef13f2a3c09285cbe1799d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aa0ffae9aa6c8fd6e2f05b345056e789
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1160befb0d118f8479a2fe35962c7798
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2ce6b741e2e48dee718ad2526483a928
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1fc63257d71f1579d15b929fa22cc16a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_039446095192f5b29061a74b2f480c7d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6335c79a862681b8e80d2c2fcc89b0a2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b1bfdf448028742553dc196648fbcadb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8e29e0e4a1a7b3a9a655a328f87a5682
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c7654cc9d4a815403c068cf0a2b97e2c
date 2011-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC3211323
https://doi.org/10.1186/1556-276x-6-260
https://pubmed.ncbi.nlm.nih.gov/21711774
isPartOf https://portal.issn.org/resource/ISSN/1556-276X
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37703
https://portal.issn.org/resource/ISSN/1931-7573
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/
title Novel docetaxel-loaded nanoparticles based on poly(lactide-co-caprolactone) and poly(lactide-co-glycolide-co-caprolactone) for prostate cancer treatment: formulation, characterization, and cytotoxicity studies
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148124
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10154203
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65432
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7272
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10401

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129159660
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128482492
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127899424
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128888398
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127584974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129571406
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129818630
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127889566
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128285311
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128397534
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128047904

Total number of triples: 50.